140 related articles for article (PubMed ID: 31095781)
1. Antiproliferative and toxicogenomic effects of resveratrol in bladder cancer cells with different TP53 status.
Almeida TC; Guerra CCC; De Assis BLG; de Oliveira Aguiar Soares RD; Garcia CCM; Lima AA; da Silva GN
Environ Mol Mutagen; 2019 Oct; 60(8):740-751. PubMed ID: 31095781
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of urinary bladder cancer cell proliferation by silibinin.
Barros TMB; Lima APB; Almeida TC; da Silva GN
Environ Mol Mutagen; 2020 Apr; 61(4):445-455. PubMed ID: 32078183
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxic and toxicogenomic effects of silibinin in bladder cancer cells with different TP53 status.
DE Oliveira DT; Savio AL; Marcondes JP; Barros TM; Barbosa LC; Salvadori DM; DA Silva GN
J Biosci; 2017 Mar; 42(1):91-101. PubMed ID: 28229968
[TBL] [Abstract][Full Text] [Related]
4. Cell cycle kinetics, apoptosis rates, DNA damage and TP53 gene expression in bladder cancer cells treated with allyl isothiocyanate (mustard essential oil).
Savio AL; da Silva GN; de Camargo EA; Salvadori DM
Mutat Res; 2014 Apr; 762():40-6. PubMed ID: 24625788
[TBL] [Abstract][Full Text] [Related]
5. Toxicogenetic and antiproliferative effects of chrysin in urinary bladder cancer cells.
Lima APB; Almeida TC; Barros TMB; Rocha LCM; Garcia CCM; da Silva GN
Mutagenesis; 2020 Aug; ():. PubMed ID: 32789469
[TBL] [Abstract][Full Text] [Related]
6. No relationship between the amount of DNA damage and the level of hMLH1 and RASSF1A gene expression in bladder cancer cells treated with cisplatin and gemcitabine.
Camargo EA; da Silva GN; Gobette CP; Marcondes JP; Salvadori DM
Asian Pac J Cancer Prev; 2013; 14(10):5941-8. PubMed ID: 24289605
[TBL] [Abstract][Full Text] [Related]
7. Toxicogenomic activity of gemcitabine in two TP53-mutated bladder cancer cell lines: special focus on cell cycle-related genes.
da Silva GN; de Camargo EA; Salvadori DM
Mol Biol Rep; 2012 Dec; 39(12):10373-82. PubMed ID: 23053941
[TBL] [Abstract][Full Text] [Related]
8. Gemcitabine/Cisplatin Treatment Induces Concomitant SERTAD1, CDKN2B and GADD45A Modulation and Cellular Changes in Bladder Cancer Cells Regardless of the Site of TP53 Mutation.
da Silva GN; Filoni LT; Salvadori MC; Salvadori DMF
Pathol Oncol Res; 2018 Apr; 24(2):407-417. PubMed ID: 28577130
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms involved in resveratrol-induced apoptosis and cell cycle arrest in prostate cancer-derived cell lines.
Benitez DA; Pozo-Guisado E; Alvarez-Barrientos A; Fernandez-Salguero PM; Castellón EA
J Androl; 2007; 28(2):282-93. PubMed ID: 17050787
[TBL] [Abstract][Full Text] [Related]
10. Radiation induces p53-dependent cell apoptosis in bladder cancer cells with wild-type- p53 but not in p53-mutated bladder cancer cells.
Hinata N; Shirakawa T; Zhang Z; Matsumoto A; Fujisawa M; Okada H; Kamidono S; Gotoh A
Urol Res; 2003 Dec; 31(6):387-96. PubMed ID: 12955365
[TBL] [Abstract][Full Text] [Related]
11. Sensitivity of TP53-Mutated Cancer Cells to the Phytoestrogen Genistein Is Associated With Direct Inhibition of Plk1 Activity.
Shin SB; Woo SU; Chin YW; Jang YJ; Yim H
J Cell Physiol; 2017 Oct; 232(10):2818-2828. PubMed ID: 27861885
[TBL] [Abstract][Full Text] [Related]
12. Resveratrol induces apoptosis and cell cycle arrest of human T24 bladder cancer cells in vitro and inhibits tumor growth in vivo.
Bai Y; Mao QQ; Qin J; Zheng XY; Wang YB; Yang K; Shen HF; Xie LP
Cancer Sci; 2010 Feb; 101(2):488-93. PubMed ID: 20028382
[TBL] [Abstract][Full Text] [Related]
13. Cell cycle arrest and apoptosis in TP53 subtypes of bladder carcinoma cell lines treated with cisplatin and gemcitabine.
da Silva GN; de Castro Marcondes JP; de Camargo EA; da Silva Passos Júnior GA; Sakamoto-Hojo ET; Salvadori DM
Exp Biol Med (Maywood); 2010 Jul; 235(7):814-24. PubMed ID: 20558835
[TBL] [Abstract][Full Text] [Related]
14. Resveratrol induces the production of reactive oxygen species, interferes with the cell cycle, and inhibits the cell migration of bladder tumour cells with different TP53 status.
Almeida TC; Melo AS; Lima APB; Branquinho RT; da Silva GN
Nat Prod Res; 2023; 37(22):3838-3843. PubMed ID: 36441214
[TBL] [Abstract][Full Text] [Related]
15. Human bladder cancer cells undergo cisplatin-induced apoptosis that is associated with p53-dependent and p53-independent responses.
Konstantakou EG; Voutsinas GE; Karkoulis PK; Aravantinos G; Margaritis LH; Stravopodis DJ
Int J Oncol; 2009 Aug; 35(2):401-16. PubMed ID: 19578756
[TBL] [Abstract][Full Text] [Related]
16. Expression of genes related to apoptosis, cell cycle and signaling pathways are independent of TP53 status in urinary bladder cancer cells.
da Silva GN; Evangelista AF; Magalhães DA; Macedo C; Búfalo MC; Sakamoto-Hojo ET; Passos GA; Salvadori DM
Mol Biol Rep; 2011 Aug; 38(6):4159-70. PubMed ID: 21116856
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of bladder cancer cell proliferation by allyl isothiocyanate (mustard essential oil).
Sávio AL; da Silva GN; Salvadori DM
Mutat Res; 2015 Jan; 771():29-35. PubMed ID: 25771977
[TBL] [Abstract][Full Text] [Related]
18. Combination of Rapamycin and Resveratrol for Treatment of Bladder Cancer.
Alayev A; Salamon RS; Schwartz NS; Berman AY; Wiener SL; Holz MK
J Cell Physiol; 2017 Feb; 232(2):436-446. PubMed ID: 27225870
[TBL] [Abstract][Full Text] [Related]
19. Small molecule inhibition of polo-like kinase 1 by volasertib (BI 6727) causes significant melanoma growth delay and regression in vivo.
Cholewa BD; Ndiaye MA; Huang W; Liu X; Ahmad N
Cancer Lett; 2017 Jan; 385():179-187. PubMed ID: 27793694
[TBL] [Abstract][Full Text] [Related]
20. MEK plus PI3K/mTORC1/2 Therapeutic Efficacy Is Impacted by TP53 Mutation in Preclinical Models of Colorectal Cancer.
García-García C; Rivas MA; Ibrahim YH; Calvo MT; Gris-Oliver A; Rodríguez O; Grueso J; Antón P; Guzmán M; Aura C; Nuciforo P; Jessen K; Argilés G; Dienstmann R; Bertotti A; Trusolino L; Matito J; Vivancos A; Chicote I; Palmer HG; Tabernero J; Scaltriti M; Baselga J; Serra V
Clin Cancer Res; 2015 Dec; 21(24):5499-5510. PubMed ID: 26272063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
